Page 56 - Glucose Monitoring Devices
P. 56

54     CHAPTER 4 Consequences of SMBG systems inaccuracy




                         (metabolism). The patient may develop a fear of hypoglycemia [36e38] and over-
                         ride its therapy parameters (behavior) [39]. Frequent hypoglycemia may also lead to
                         decreased hypoglycemia awareness [40], increased glucose variability, and reduced
                         autonomic response during counterregulation [41]. This is in addition to intraday
                         and interday variability of the patient’s metabolism, exercise, stress, and other
                         hormonal changes. A different metabolic state will make the same BGM system
                         error have different effects.

                         Patient behavior is the main driver

                         Behavior is a fundamental part of this control system and, in the absence of auto-
                         mated insulin delivery systems, it is the main driver of glycemic control [42,43].
                         The stated (nominal) goal of this system is to properly control glucose; nevertheless,
                         patients have subtle, adaptive, and context-varying goals, such as reducing stress
                         [44], social pressure [45,46], and time required to manage their disease. Variability
                         in therapy modes, devices, drugs, and, most importantly, the natural physiological
                         variability often require patients to continuously adjust their behavior. Despite
                         efforts to standardize the management of diabetes, from the patient’s vintage point
                         diabetes management is still a heavy cognitive challenge requiring frequent adapta-
                         tion, which involves switching therapy modes, adjusting exercise, food intake,
                         hypoglycemia self-treatment, and insulin dosing strategies. This constantly chang-
                         ing environment makes it hard to isolate and adequately quantify what, if any, is
                         the contribution of BGM system accuracy to outcomes. In Fig. 4.3 we illustrate
                         some of these behaviors, following an approach similar to Ref. [47]. Upon entering

                                     Hyperglycemia                       Hypoglycemia


                                       Aware?                              Aware?


                               Ignore                                                   Ignore


                               Ignore  Fingerstick                        Fingerstick   Ignore


                               Denied                                               Denied

                           OK                                                 Eating soon  OK
                          (false)                                                      (false)
                                                            Treatment Carb
                                  Ignore    Bolus  Exercise           Eat Early
                                                                    (medical eating)
                                                                              Ignore  Ignore
                                       Eyeball
                                                Follow
                                             Functional Therapy
                         FIGURE 4.3
                         An example of choices around hypo/hyperglycemia.
   51   52   53   54   55   56   57   58   59   60   61